European Equities Traded in the US as American Depositary Receipts Start Week Down Slightly in Monday Trading

European equities traded in the US as American depositary receipts were trending slightly lower late Monday morning, declining 0.16% to 1,278.01 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by pharmaceutical company Novo Nordisk (NVO) and semiconductor company Sequans Communications (SQNS), which rose 3.2% and 2.8% respectively. They were followed by medical device maker EDAP TMS (EDAP) and accommodations booking company trivago (TRVG), which were up 2.7% and 1.5% respectively.

The decliners from continental Europe were led by furniture maker Natuzzi (NTZ), which fell 2.9%, followed by biotech firm Evaxion Biotech (EVAX) and internet advertising firm Criteo (CRTO), which lost 2.3% each. They were followed by 3D printer company Materialise (MTLS), which was down 2%.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Verona Pharma (VRNA) and TC Biopharm (TCBP), which rose 3.7% and 3.1% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and software firm Endava (DAVA), which increased 2.1% and 1.8% respectively.

The decliners from the UK and Ireland were led by cruise line operator Carnival (CUK) and biotech firm Autolus Therapeutics (AUTL), which dropped 4.3% and 3.5% respectively. They were followed by biopharmaceutical company Mereo BioPharma Group (MREO) and pharmaceutical company Silence Therapeutics (SLN), which lost 3.3% and 3.2% respectively.